Randox is new patron for NI Chamber of Commerce

Randox is new patron for NI Chamber of Commerce

Randox Logo

   

25th MARCH 2021

Northern Ireland Chamber of Commerce and Industry (NI Chamber) has announced that Randox, the UK and Ireland’s largest diagnostics company, is its newest Patron organisation.

As a new NI Chamber Patron, Randox joins a select group of leading businesses, who lend their support to the development of the region’s economy and business community. The partnership offers mutual benefit and will see Randox experience increased brand exposure among the business community and close association with a leading membership organisation.

Announcing the partnership, Ann McGregor, Chief Executive, NI Chamber said:

“Randox has a long relationship with NI Chamber and I am delighted to announce that the company has decided to strengthen its association with us, by coming on board as a Patron.

“Having the support of one of Northern Ireland’s leading exporters is a real endorsement of the work we do and in particular, the support NI Chamber has provided to companies over the past 12 months. As we continue to help firms in all sectors to restart and grow, we look forward to working with Randox and indeed all of our Patrons.”

Dr Peter FitzGerald, Managing Director of Randox, added:

“We are delighted to be welcomed as a patron of Northern Ireland Chamber of Commerce and Industry. As a leading life science company with global export markets, Randox very much values the contribution of the Chamber – particularly so at a time of significant change related to Brexit and the impact of COVID-19.  We are ambitious for the future and see the potential for significant growth, as the importance of diagnostics and preventative healthcare grows.  We look forward to working with Ann and the Chamber team as we rise to meet the challenges and seize the opportunities to grow our economy – for the benefit of all our people.”

Established in 1982, Randox is the largest diagnostics company from the UK and Ireland; focusing on the provision of accurate and timely health testing. By identifying risk to health, improving clinical diagnoses and promoting preventative healthcare, Randox technologies are used to achieve better health outcomes whilst reducing the burden on clinical services.   The company’s innovative and comprehensive portfolio includes tests for diabetes, Alzheimer’s disease, cancer, stroke and COVID-19. In 2019 Randox manufactured over 4 billion tests, and operated in 145 countries.  With over 2000 staff, including more than 450 research scientists and engineers, key facilities are located in Co Antrim and Co Donegal.

Randox joins a list of NI Chamber Patrons which also includes Caterpillar, Danske Bank, DSV, fonaCAB, Investec, Moy Park, Pinsent Masons, Power NI, Queen’s University, Ulster Bank, Ulster Carpets and Ulster University Business School.

For further information please email Amy Millar, Public Relations Team Leader on amy.millar@randox.com or 028 9442 2413

 

Randox in the media

Latest News

FAQs


Record level of alcohol deaths recorded during COVID-19 pandemic

Record level of alcohol deaths recorded during COVID-19 pandemic

22 March 2021

Deaths caused by alcohol consumption hit a new high during the first nine months of 2020, new figures for England and Wales show.

Between January and September, 5,640 deaths were registered with this cause – an increase of 16% on the same period in 2019. This significant increase has been the highest recorded figure since records began in 2001. The high rates spanned the period during and after the first national COVID-19 lockdown, according to new figures from the Office for National Statistics.

As in past years, rates of male alcohol-specific deaths were twice those seen for women. Experts say the coronavirus pandemic will have had little effect on how the data was gathered and recorded. But it is not clear how much it may have contributed to the deaths.

A spokesman for ONS said:

“Today’s data shows that in the first three quarters of 2020, alcohol-specific deaths in England and Wales reached the highest level since the beginning of our data series, with April to September, during and after the first lockdown, seeing higher rates compared to the same period in previous years.”

“The reasons for this are complex and it will take time before the impact the COVID-19 pandemic has had on alcohol-specific deaths is fully understood.”

Effects of Alcohol

Alcohol’s impact on your body starts from the moment of consumption. While an occasional glass of wine or beer isn’t a cause for concern, the cumulative effects of drinking beer, wine or spirits can take its toll.

Excessive consumption can impact various parts of the body. Effects can range from weakening of the immune and digestive system, to inflammation and sugar level issues.

Our ‘Effects Of’ Series provides a range of educational posters that ca be displayed in workplaces. Click here to view them.

Did you know that alcohol misuse at work can:

  • increase sickness and absenteeism
  • harm the reputation of the business
  • decrease productivity
  • put employees and members of the public in unnecessary risk

Breath Testing in the Workplace

Handheld breathalysers are an ideal device for conducting workplace alcohol testing. Quick and easy testing provides an instant readout of the donor’s breath alcohol measurement.  Simply compare the reading to the cutoff defined in your own drug and alcohol testing policy.

Breathalyser devices gauge blood alcohol content (BAC) by measuring deep lung air. This type of testing can accurately determine whether a person has recently consumed alcohol or is currently over the legal or pre-determined limit. Breathalyser calibrations are maintained in accordance with the manufacturers specifications and periodically accuracy checked to ensure results are accurate and reliable.

How Randox Testing Services can help

At Randox Testing Services, we are pleased to offer a range of stand-alone alcohol tests or combinations of tests to meet your needs.

Throughout the COVID-19 pandemic, RTS have continued to provide drug & alcohol testing services. At all times, we have ensured our staff are equipped to provide sensible advice and flexible solutions to drug & alcohol testing.

Whether for use in workplace settings or for use in court proceedings for medico-legal cases, our range of alcohol testing methods will provide you with accurate and reliable results at competitive prices.

For more information on our alcohol testing services, or to request a quote, contact us using any of the below details.

Website: www.randoxtestingservices.com

Email: testingservices@randox.com

Phone: +44 (0) 28 9445 1011

For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.

Want to know more?

Contact us or visit our website to read more.


Randox Quality Control launches new Acusera D-Dimer Controls

Randox Quality Control launches new Acusera D-Dimer Controls

16 March 2021: Randox Quality Control launches new Acusera D-Dimer Controls

Randox Quality Control has launched a new range of Acusera Controls for the accurate and reliable testing of D-Dimer.

Providing a true third-party solution for D-Dimer testing, which is most often used to investigate whether a patient has a blood clotting disorder, this control is manufactured for use on a range of different diagnostic systems.

Designed to provide accurate and reliable patient testing, this control comes in a liquid frozen format and is stable for an impressive 28 days when stored at 2ºC to 8ºC.

Three levels are supplied, spanning the full clinical range and FEU.

Features and Benefits

  • Liquid frozen
  • 100% human serum
  • 2 year shelf life from date of manufacture
  • Cut-off level of 500 ng/ml (FEU) for most analysers
  • Open vial stability of 28 days at 2°C – 8°C
  • Assayed Control

For more information visit https://www.randox.com/d-dimer-internal-quality-control/

 

 

QUALITY CONTROL

REAGENTS

RX SERIES


The Impact of Coronavirus on Drug Use in Europe

News       About Us        Randox Toxicology

15 March 2021: Impact of Coronavirus on Drug Use in Europe

The effect of COVID-19 on the consumption of drugs in Europe has been varied depending on the drug type concerned. Overall, 51.6% of participants in a survey have increased their drug or alcohol consumption and 57.3% reported taking drugs more frequently. The main explanations for these inclines are due to boredom and anxiety, likely due to the imposed restrictions of strict lockdown measures.

According to Statista, Cannabis remains to be the most popular drug used within Europe as 27.2% of respondents revealed that they have used the drug in their lifetime compared to only 5.4% using cocaine. Since the COVID-19 pandemic began in March 2020, regular users of Cannabis have increased their usage, however it is important to note that this has only affected 10% of respondents.

There has been a major hold on the party lifestyle with the shut-down of nightclubs and lack of festival events. As well as, a decrease in the supply of readily available drugs on the market resulting from transport restrictions at country borders. This has impacted the usage of recreational drugs such as cocaine, LSD and MDMA which have seen a decline. The Global Drug Survey revealed that 40% of respondents have used these drugs less during the pandemic.

This detrimental trend has resulted in the domestic production of synthetic opioids. There is a very high risk that substitutes such as fentanyl will become more common. This prediction is concerning due to the dangers associated with such drugs leading to addiction and overdoses. For instance, fentanyl compared to heroin is 50 times stronger.

Public Health England has also released a warning relating to the rise in illegally produced prescription drugs sold as benzodiazepines. These cause harmful health issues due to the mix of unsafe and unknown components.

Randox Toxicology

Randox Toxicology are helping to fight drug trafficking by continually investing in new technologies to aid in the rapid and large-scale screening for drugs of abuse. We are world leaders in drug screening solutions with the capability of detecting over 500 drug and drug metabolites using our innovative Biochip Array Technology – the most comprehensive on the drug testing market. Our patented Biochip Array Technology works across a variety of matrices including whole blood, urine, oral fluid, meconium, vitreous humor and hair.

Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in non-laboratory settings for people with no lab experience.

To find out more about our Biochip Array Technology and our Evidence Series range of analysers, visit www.randoxtoxicology.com or email info@randoxtoxicology.com

 

For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.

Randox Toxicology Products and Services

BIOCHIP

EVIDENCE

ELISA

MATRICES

Want to know more about Randox?

Contact us or visit our homepage to view more.


SARS-CoV-2 (COVID-19) Antigen Testing Pilot Study from Randox Quality Control

News       Coronavirus       QCMD

 

SARS-CoV-2 (COVID-19) Antigen Testing Pilot Study

12 March 2020

SARS-CoV-2 (COVID-19) Antigen Testing Pilot Study

Randox, in partnership with QCMD, is pleased to announce a new QCMD EQA pilot study for SARS-CoV-2 (COVID-19) Antigen Testing. This new pilot is designed to evaluate a laboratory’s ability to detect SARS-CoV-2 (COVID-19) antigen and will provide an opportunity to assess performance against an international peer group.

QCMD is a world leading EQA / Proficiency Testing (PT) provider, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases. With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the fi eld of infectious disease testing.

Features & Benefits

  • null

    Whole PathogenAvailability of whole pathogen samples containing the entire viral genome, ensures commutability with the majority of commercial assays.

  • null

    Smart-Phone App Results SubmissionResults can be returned via a smart-phone app so that participants using lateral flow devices can provide pictures of their device/result with the phone camera.

  • null

    Comprehensive ReportsA real-time rapid report will be provided on submission of results. An individual report is received after each challenge, summarising laboratory performance in comparison to an international peer group.

  • null

    EQA Management SystemIT EQA Management System (ITEMS) provides an online tool to easily manage all EQA activities from programme registration to submission of results and provision of EQA reports.

  • null

    Not infectiousSamples containing SARS-CoV-2 antigens are inactivated and not infectious ensuring safe handling of material.

  • null

    Suitable for Point of CareSamples are supplied liquid ready-to-use ensuring they are ideal for use at the point care.

     

    For more information visit https://www.randox.com/qcmd-sars-antigen-testing/

    For further enquiries please email marketing@randox.com

    QCMD

    QNOSTICS

    CORONAVIRUS


    11th March 2021: 11 million tests on the National Testing Programme

    Randox Logo

       

    11TH MARCH 2021: THE 11 MILLION MILESTONE 

    We are pleased to let you know that on 11th March 2021, Randox processed its 11 millionth sample within the UK COVID-19 National Testing Programme.

    That’s an incredible 11 million samples processed by our dedicated and talented staff.

    Our staff are our best asset and have risen to the challenge this pandemic has created.

    They have worked hard and flexibly, been creative and innovative, and pulled together as a team to make an impact in the fight against COVID-19.

    We are very proud of their efforts and teamwork.

    Let us once again say thank you to each and every member of Team Randox, for the efforts they have made.

    What we do at Randox remains vital to the national and global management of COVID-19 and our work is making a real and positive difference.

    We continue to work hard and improve, for the sake of our family, friends and communities.

    For further information please email randoxpr@randox.com

    Randox in the media

    Latest News

    FAQs


    Randox launches COVID-19 Testing Drive-Through at Dun Laoghaire Harbour

    Randox launches COVID-19 Testing Drive-Through at Dun Laoghaire Harbour

    03 March 2021

    Randox launches COVID-19 Testing Drive-Through at Dun Laoghaire Harbour

    A €99 Express COVID-19 Testing Service launches this week in a new Drive-Through Testing Centre at Dun Laoghaire Harbour.

    The testing service from Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, utilises a robust and reliable method of testing known as PCR, which is currently the only method of COVID-19 testing recognised and approved by every country worldwide.

    The launch of the Dun Laoghaire Harbour Drive-Through, which offers rapid next day delivery of results, can be used for pre-departure screening, on-arrival testing to reduce quarantine timeframes, or simply for peace of mind.

    Sophie Boyd, Project Manager for the Randox COVID-19 Testing Service, explained;      

     “In addition to our Travel Centres in Dublin, Limerick, Sligo and Galway, we are pleased to open our new Drive-Through testing service in Dun Laoghaire, to serve South County Dublin with our accurate and cost-effective COVID-19 test.

    “Whilst restrictions and guidance during the pandemic continue to evolve, testing will remain a key part of the response to COVID-19 – not only to identify outbreaks, isolate cases and prevent further spread, but also to assist with a return to social and economic normality.”

    Ireland is currently part of the EU ‘traffic lights’ system which coordinates international travel, meaning that anyone leaving Ireland, currently orange on the traffic light scale, can avoid quarantine on arrival if they obtain a negative PCR test result before departure.

    Those arriving in Ireland – depending on their departure country – may be able to reduce their on-arrival quarantine timeframe by taking a COVID-19 test no less than 5 days after arrival.

    Sophie continued;

    “The Randox Health COVID-19 testing drive-through at Dun Laoghaire Harbour is another positive step towards the normalization of travel and other social activities, for the residents of Dun Laoghaire Rathdown and across South County Dublin.

    “Anyone who is interested in booking a test can do so at the Randox Health booking website, and will have their results returned to them the next day.”

    The Randox €99 Express COVID-19 Testing Service is open to all asymptomatic individuals and operates from the Randox Health Drive-Through at Dun Laoghaire Harbour.

    Randox Health PCR Testing is also available at Terminal 2 at Dublin Airport, and in Leopardstown Dublin, Limerick, Sligo, Cork and Galway.

    Visit booking.randox.ie to book your appointment.

     

    Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.

    Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).

    COVID-19 antibody testing is available in Randox Health Clinics.

     

     

     

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our COVID-19 Products and Services

    HOME TEST

    ANTIBODY TEST

    TRAVEL CERTIFICATE

    LABORATORY TOOLS


    COVID-19 Antigen Testing launched at Dublin Airport

    COVID-19 Antigen Testing Service launched at Dublin Airport

    22 February 2021

    Travelling to a country that requires antigen testing?

    Antigen Testing is the fastest and cheapest of all lab tests for COVID-19 and is now available at our Dublin Travel Centre for just €49.  Testing is conducted using a nose and throat (nasopharyngeal) swab with your results available within 1 hour.

    Sometimes called a ‘lateral flow test’, it will reveal if a person is currently infected with a pathogen such as SARS-CoV-2 – the virus that causes COVID-19.  Unlike a PCR test (which detects the presence of genetic material) antigen tests detect proteins or glycans, such as spike proteins found on the surface of the COVID-19 virus.

    Paul Turnbull, Randox Global Business Manager says;

    “When it comes to travel, we started to see more and more countries across Europe state that they would only accept a negative PCR result and that has remained the case, as countries only want the most sensitive technology.  Some countries however, such as the Netherlands, Germany & Sweden, require antigen testing as a secondary test before entry.”

    Antigens remain in the body during infection and disappear once the COVID-19 infection has gone, so testing for antigens can identify those who whilst asymptomatic, are currently infected with, and could still be spreading the virus.  It is thought that around 1 in 3 people with COVID-19 do not have symptoms, so a test that rapidly detects these otherwise hidden cases is a very useful additional tool for tackling the virus.

    It is important to note that no test is 100% accurate and all tests have limitations. The preferred testing for COVID-19 is still the gold standard PCR testing due to its high sensitivity methodology.  PCR testing requires samples to be sent back to our COVID-19 laboratory in County Antrim, which is why it can take up to 24hours to receive results for a PCR test, as opposed to 1 hour for antigen testing.

    The Randox Health Dublin Airport Testing Centre offers both PCR and Antigen testing for travel and peace of mind.

    Before booking an antigen testing appointment please confirm with your destination that this method is accepted as a means for entry.   If flying the same day, please book your test 4 hours before your flight departure time.

    Visit booking.randox.ie to book your appointment.

     

    Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.

    Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).

    COVID-19 antibody testing is available in Randox Health Clinics.

     

     

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our COVID-19 Products and Services

    HOME TEST

    ANTIBODY TEST

    TRAVEL CERTIFICATE

    LABORATORY TOOLS


    The race that never was: 2020 Randox Health Grand National trophy is unveiled at 2021 Weights event – with a special tribute to the late Rose Paterson

    Randox Logo

       

    16 February 2021:

    The race that never was: 2020 Randox Health Grand National trophy is unveiled at 2021 Weights event – with a special tribute to the late Rose Paterson

    The trophy for the 2020 Randox Health Grand National – the race that never was – has been unveiled today during the 2021 Weights event, with a special tribute to the late Rose Paterson.

    Shown to the public for the first time during the event which was shown live on Racing TV, the 2020 trophy was designed by silversmith Cara Murphy, who like Randox, is also from Northern Ireland.  The design reflects Randox’s commitment to better healthcare through improved testing.

    Having made the trophy in 2020, Cara has since been commissioned by Randox to update the design with a delicate silver rose on its edge, to honour the memory of Aintree Chairman Rose Paterson.

     

    Dr Peter FitzGerald, Randox Managing Director, commented;

     “It is very fitting that this wonderful trophy should be shown now, at a time when we all have a better understanding and appreciation of diagnostic testing, as a result of the terrible COVID-19 pandemic.

    “But I am particularly pleased that with its unveiling, we can pay tribute to the remarkable Rose Paterson.  Rose, in her role as Chairman of Aintree, had remarkable vision and energy and achieved so much for the racing public, for the owners, trainers and jockeys and, most importantly, for equine welfare. 

    “She was a wonderful person to know, both personally and professionally, and really made a lasting mark at Aintree.  She will be greatly missed and we extend our deepest sympathies to Owen and the whole family.”

    Designed in solid silver, the 2020 trophy, which features unique and intricate stands of gold proteins and antibodies held within a 50cm diameter circle, differs to that of its 2017, 18 and 19 counterparts by way of its shield-like shape.

    Encircling the outside of the shield is the Biochip – Randox’s proprietary technology for diagnosis of ill-health and disease – and a red enamel roundel is positioned in the logo, symbolising a drop of blood which enables Randox to carry out a range of innovative tests.

    Silversmith Cara Murphy commented;

     “Little did I know when I began researching Randox’s testing capabilities, that it would go on to play such a prominent role in the national response to the COVID-19 pandemic, and that words like testing and antibodies would now be used so regularly in everyday conversation.

    “Almost a year since the trophy was completed and things have changed so significantly – but I was honoured to have the opportunity to commemorate the life of Aintree Chairman Rose Paterson in the update we have made to my design.

    “The 2020 trophy has been a fantastic project to work on, and a great Northern Ireland collaboration between Randox and myself.”

    As in previous years, the 2020 Randox Health Grand National trophy is accompanied by miniature team trophies. In their first year as sponsor, Randox introduced the concept of presenting the entire winning team with a trophy, to celebrate the combined effort that goes in to achieving such a special victory. In both 2018 and 2019, they went to Tiger Roll’s winning team; trainer Gordon Elliott, jockey Davy Russell, and groom Louise Dunne.

    A new charity in honour of the life of Rose Paterson, The Rose Paterson Trust, is due to be launched at the Randox Grand National in April 2021.

    For further information or to organise interviews please email Amy Millar in the Randox PR team on randoxpr@randox.com or phone 028 9442 2413.

     

     

    Randox in the media

    Latest News

    FAQs


    Biotin supplementation interference in health testing

    Randox Logo

    12 February 2021

    Biotin supplementation interference in health testing

    How much do you know about Biotin? Commonly known as Vitamin B7, Biotin is taken by as many as 20% of people, including high profile celebrities like Kylie Jenner, Kim Kardashian and Vanessa Hudgens, for its hair and nail-strengthening properties.

    If you take biotin supplements, it is important to know the effects it can have on particular blood tests, should you visit your GP or local hospital.

    Whilst there are various diagnostic health tests out there, including fertility hormone tests, prostate tests, and tests for troponin – a marker released into the blood during a heart attack – that are known to be affected by elevated levels of biotin, there are other tests available, including those provided by Randox, that are not impacted.

    The reason that so many non-Randox tests are impacted by biotin is that biotin is widely used throughout the biotechnology industry in the development of diagnostic tests.

    ELISA tests in particular (tests that measure the reaction of antibodies to identify a substance) often make use of antibodies labelled with biotin, to detect toxins or other foreign substances within the body.

    In most instances, the biotin will bind to a protein called streptavidin. This bonding is the strongest non-covalent biological interaction known, and is therefore particularly useful in binding antibodies within diagnostic tests.

    But with more and more people exceeding the recommended daily dosage for biotin (30 micrograms) by taking up to 10,000 micrograms of biotin in supplements marketed for beauty reasons, many diagnostic tests are being measured inaccurately. Excess biotin in the blood can block the binding of biotin-labelled antibodies to streptavidin within the tests, and the substance being tested won’t be measured accurately.

    Laboratory professionals have known about this potential problem for some time. In late November 2017, the FDA (Food and Drug Administration) published a safety notice to make the public and healthcare practitioners more aware that biotin can “significantly interfere with certain lab tests and cause incorrect test results.”

    The FDA even reported on one particular case in which a patient died following falsely low troponin (marker of a heart attack) results when the troponin test used was known to have biotin interference. Biotin supplements masked the true diagnosis of a heart attack.

    Many patients taking biotin supplements have also been misdiagnosed with a condition called Graves’ disease, an autoimmune condition characterised by an overactive thyroid. In these cases, biotin supplementation led to falsely low levels of thyroid stimulating hormones, and falsely high levels of other thyroid hormones. This particular profile of hormones led to a Graves’ disease diagnosis, in spite of a lack of symptoms, which in Graves’ disease would usually include muscle weakness, a quickened heartbeat, sleeping problems, diarrhoea, weight loss and poor tolerance of heat.

    In pregnant women, tests that are impacted by biotin interference may produce falsely low results of beta HCG, more commonly known as the ‘pregnancy hormone’ as it released by the placenta after conception. With low levels of beta HCG, and therefore no confirmation of pregnancy, pregnant women could be exposed to X-rays and CT scans that may harm the developing foetus.

    So, what can be done? Suggestions have been made that patients taking biotin supplements should be made to wait before any diagnostic testing is conducted, so that the biotin clears from their system.

    But this “Wait and Watch” approach certainly would not work in emergencies. In the case of a heart attack, testing must be conducted as soon as possible to allow for diagnosis, immediate medical intervention and follow-up testing.

    At Randox, we are convinced that the risk of analytic interference by biotin supplementation is a serious problem that needs to be more widely recognised and promptly addressed.

    In the GP setting, general practitioners must ask their patients if they are taking any biotin supplements and inform the testing laboratory if interference from biotin is a possibility. They should also consider that lab results not matching with a patient’s signs and symptoms may be caused by biotin interference.

    In the acute care setting however, it is imperative that biotin technology is not used in diagnostic testing to protect patients from misdiagnosis and subsequently, further health problems.

    This is why Randox’s patented Biochip Array Technology does not use biotin technology in its development. This revolutionary methodology, free from Biotin-Streptavidin is not impacted by elevated levels of biotin from supplementation in the same way as Biotin-Streptavidin tests.

    So if you have been taking supplements for hair or nail growth, to ease symptoms associated with Multiple Sclerosis, for epilepsy or for a range of other health conditions, and your diagnostic testing has been conducted using Randox Biochip Array Technology, you can rest assured of true, accurate, and reliable results.

    Randox Biochip Array Technology is interference-proof.

    For further information on the Randox Biochip, visit https://www.randox.com/multiplex-testing/

    For any additional questions, please contact Randox PR by email: randoxpr@randox.com or by phoning 028 9442 2413

    Want to know more about Randox?

    Contact us or visit our homepage to view more.

    Our COVID-19 Products and Services

    HOME TEST

    ANTIBODY TEST

    TRAVEL CERTIFICATE

    LABORATORY TOOLS


    Request a meeting
    ×
    Make an Enquiry - RX series
    ×
    Make an Enquiry - Reagents
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Kit Insert Request - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Reagents
    ×
    Make an Enquiry - Quality Control
    ×
    Make an Enquiry - RIQAS
    ×
    Make an Enquiry - RIQAS
    ×
    Make an Enquiry - Quality Control
    ×
    Make an Enquiry
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Biochip
    • This field is for validation purposes and should be left unchanged.
    ×
    Make an Enquiry - Molecular
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    • This field is for validation purposes and should be left unchanged.
    ×
    Make an Enquiry - Future Diagnostics
    ×
    Make an Enquiry - RX series (Product)
    ×
    Make an Enquiry - Quality Control
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - RIQAS
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Make an Enquiry - Reagents
    • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
    ×
    Por favor, introduzca sus datos para ver nuestro último seminario